These can overlap, but each points to different next steps
Some rough grades: BPC-157: D+ for injury/gut-repair KPV: D for gut/skin inflammation TB-500: D- for injury-recovery MOTs-C: D+ for metabolic-signal claims
While it's already planning Phase 3 testing based on what it's finding right now in its Phase 2b testing of low and medium monthly maintenance dosing for 64 weeks, it could be a while before this drug candidate could be approved and commercialized
Some of the major players in the market are- Kyowa Hakko Bio Co., Ltd., Nissor Pharmaceuticals Ltd., Shenzhen GSH Bio-tech Co., Ltd, KOHJIN Life Sciences Co., Ltd, Anhui GSH Bio-Technology Co., Ltd, Kaiping Genuine Biochemical Pharmaceutical Co., Ltd, Herbo Nutra, Haihang Industry Co., Ltd., Meteoric Biopharmaceuticals Pvt
Studies have shown that ortho-carbonyl bicyclic hydroquinone can induce a decrease in mitochondrial membrane potential and ATP levels, and significantly inhibit platelet aggregation
To further reduce contamination risks, aliquot the reconstituted solution into sterile microtubes and label each one with the contents, concentration, and reconstitution date